https://www.statnews.com/2020/01/12/venture-capitalist-alexis-borisy-bring-down-drug-prices/ … Does anybody understand why this business model hasn't been done before? (Develop new drugs that mimic the effects of other approved drugs; sell them at lower prices; make a profit by gaining market share.)
-
-
Why isn't it obvious that insurance companies would prefer to cover a (FDA-approved, proven-equivalent) cheap drug over an expensive drug for the same disease? Even monopolies and oligopolies have an interest in lowering their *costs*.
Show this thread -
This is the kind of scenario that makes me think about
@TheZvi's dictum that "people just don't like money" (he's often said this about people whose gambling or financial bets predictably lose) but I hesitate to make that judgment about an industry I don't know well.Show this thread
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.